Malkolak Guest Lecture on Inhibition of Smad 2/3 Signaling Pathway by ACE-536 Mitigates Ineffective Erythropoiesis in β-Thalassemia and Myelodysplastic Syndromes By Dr Rajasekhar Suragani Staff Scientist, Acceleron Pharma Inc, Cambridge, USA | 14th May 2013

Malkolak Knowledge Centre cordially invites you to attend a

Guest Lecture on

“Inhibition of Smad 2/3 Signaling Pathway by ACE-536 Mitigates Ineffective Erythropoiesis in β-Thalassemia and Myelodysplastic Syndromes”

By: Dr. Rajasekhar Suragani, Ph. D

Staff Scientist, Acceleron Pharma Inc, Cambridge, MA, USA .

On

14th May 2013 (Tuesday) from 5:00 to 6:00 PM

At

Malkolak Knowledge Centre
101, Maitrivanam, Ameerpet, Hyderabad, A. P.

Organized by

Malkolak Institute of Life Sciences, Malkolak Centre for Molecular Biology

Event Contact Person: Dr. Laxminarayana Burela, Ph. D.
E-mail: burela@malkolak.in, Contact No. 040-40126777
Cell: 9640048158, URL: www.malkolak.in

Advertisement:

www.malkolak.in/Malkolak%20Guest%20Lecture%20by%20Dr%20Rajasekhar%20Suragani.pdf